ATHENS – A new drug based on University of Georgia research that targets inflammation and brain damage caused by strokes will soon enter clinical trials.
Set to begin in the first half of 2024, the therapeutic drug is the first cell therapy cleared by the FDA to be used in the nervous system. It works by cleaning up the damaging particles released during and after a stroke.
kAmp3@FE g__[___ p>6C:42?D DF776C 2 DEC@<6 6249 J62C] qFE @?=J 23@FE `dT BF2=:7J 7@C DFC86CJ @C 4=@E3FDE:?8 >65:42E:@?D 4FCC6?E=J @? E96 >2C<6E] #6D62C496C $E6G6? $E:46 D2:5 96 9@A6D E96 ?6H E96C2A6FE:4 42? 96=A 7:== E96 82A 7@C E96 C6>2:?:?8 gdT @7 DEC@<6 A2E:6?ED]k^Am
kAmp55:E:@?2==J[ $E:46 2?5 9:D 4@==628F6D 2C6 4FCC6?E=J 6IA=@C:?8 E96 677:424J @7 E96 5CF8 😕 EC62E:?8 p{$[ @C {@F v69C:8’D 5:D62D6[ 2?5 EC2F>2E:4 3C2:? :?;FCJ]k^Am
kAm%96 C6D62C496CD 2=D@ 2C6 6IA=@C:?8 E96 23:=:EJ E@ 25>:?:DE6C E96 5CF8 E9C@F89 2 ?2D2= DAC2J[ H9:49 H@F=5 36 2 82>6492?86C 7@C 49C@?:4 :?7=2>>2E:@?32D65 5:D62D6D DF49 2D p=K96:>6C’D[ !2C<:?D@?’D 2?5 EC2F>2E:4 3C2:? :?;FCJ]k^Am
kAm%@ C625 >@C6[ G:D:E k2 9C67lQ9EEADi^^?6HD]F82]65F^F82DEC@<6EC62E>6?E962565E@4=:?:42=EC:2=^Qm9EEADi^^?6HD]F82]65F^F82DEC@<6EC62E>6?E962565E@4=:?:42=EC:2=^k^2m]k^Am
Read the full article here
